A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Saglam, Sezer; Aykan, N.; ŞAKAR, Burak; GÜLLÜOĞLU, Mine; Balik, Emre; Karanlik, Hasan

doi:10.3978/j.issn.2078-6891.2010.030

A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Atıf İçin Kopyala

Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, cilt.2, sa.1, ss.19-26, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 2 Sayı: 1
Basım Tarihi: 2011
Doi Numarası: 10.3978/j.issn.2078-6891.2010.030
Dergi Adı: JOURNAL OF GASTROINTESTINAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.19-26
İstanbul Üniversitesi Adresli: Evet

Özet

Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusional 5-FU. This study aimed to evaluate the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) regimens in AGC outpatients.